SHARE

Mind Solutions Inc (OTCMKTS:VOIS) has been facing the touch times recently. The stock price posted strong gains in February, and earlier in the month of March. In fact the price made a high of $0.0055. However, the high levels could not be sustained as the stock price gradually started its downward trend. The deep drop in VOIS share prices astonished many investors as Mind Solutions is a progressive technology entity. In addition, it is working on the brain-computer-interface solutions.

What financials reflects?

The prime reason behind the sharp decline gets clear after the financial numbers of Mind Solutions are studied. As per the latest report posted few weeks ago, the company announced cash balance of $113,000. It posted liabilities of $3 million whereas the annual revenue stood at $100,000. The company recorded an annual loss of $1.4 million. It is evident that the financial numbers are lacking strength.

The disappointment

The financial performance brings disappointment for investors especially when they are hopeful about Mind Solutions new device. The company recently said that the customers interested to buy BCI device can place pre-orders staring from April 28, 2015.

The trend

Earlier in the week, the stock price of Mind Solutions declined over 20% to trade around $0.0023 per share. It clearly indicated that the total fall that VOIS stock price witnessed since its peak level in March now totals to 60%. Last trading session brought relief to the company as the stock price surged 25% to close the trading session at $0.00175 with share volume of 59.68 million against the average volume of 63.41 million.

The news

Mind Solutions Inc (OTCMKTS:VOIS) informed that the team visited design entity. All the required advancements pertaining to the mobile BCI have been done. The device is in the final phases of development and will be soon offered for sale. Therefore, the company has even announced the date for pre-orders.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

https://www.journaltranscript.com/disclaimer

LEAVE A REPLY